3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Changes in inflammatory markers and efficacy analysis of continuous subcutaneous insulin infusion in senior patients with type 2 diabetes mellitus hospitalized with community-acquired pneumonia: a randomized controlled trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The purpose of this study is to analyze the changes in inflammatory markers and efficacy in the treatment of senior patients with type 2 diabetes mellitus (T2DM) and community-acquired pneumonia with continuous subcutaneous insulin infusion (CSII).

          Related collections

          Author and article information

          Journal
          Eur Geriatr Med
          European geriatric medicine
          Springer Science and Business Media LLC
          1878-7649
          1878-7649
          Apr 2024
          : 15
          : 2
          Affiliations
          [1 ] Department of Endocrinology, Qingdao The Eighth People's Hospital, No.84 of Fengshan Road, Licang District, Qingdao, 266103, China. huanfadingdhf@126.com.
          [2 ] Department of Nephrology, Qingdao The Eighth People's Hospital, Qingdao, 266103, China.
          [3 ] Department of Outpatient, Qingdao The Eighth People's Hospital, Qingdao, 266103, China.
          [4 ] Department of Endocrinology, Qingdao The Eighth People's Hospital, No.84 of Fengshan Road, Licang District, Qingdao, 266103, China.
          [5 ] Department of Respiratory and Critical Care Medicine, Qingdao The Eighth People's Hospital, Qingdao, 266103, China.
          Article
          10.1007/s41999-023-00915-6
          10.1007/s41999-023-00915-6
          38194052
          75354cd9-15d1-4af1-ba56-27f1729f1f8c
          History

          Continuous subcutaneous insulin infusion,Type 2 diabetes mellitus,Community-acquired pneumonia,C-reactive protein; inflammatory markers

          Comments

          Comment on this article